Minimal Important Difference (MID) of the Dermatology Life Quality Index (DLQI): Results from patients with chronic idiopathic urticaria

Overview of attention for article published in Health and Quality of Life Outcomes, May 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

policy: 1 policy source

patent: 2 patents

Citations

dimensions_citation: 95 Dimensions

Readers on

mendeley: 44 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

METHODS FOR TREATING CHRONIC INDUCIBLE COLD URTICARIA BY ADMINISTERING AN IL-4R ANTAGONIST

Application WO-2024047021-A1

World Intellectual Property Organisation (WIPO)

METHODS FOR TREATING CHRONIC SPONTANEOUS URTICARIA BY ADMINISTERING AN IL-4R ANTAGONIST

Application WO-2023009437-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.